New selective inhibitors of cap dependent proteins: synthesis, delivery and chaos (Q84205)

From EU Knowledge Graph
Revision as of 13:45, 26 March 2020 by DG Regio (talk | contribs) (‎Changed an Item)
Jump to navigation Jump to search
Project in Poland financed by DG Regio
Language Label Description Also known as
English
New selective inhibitors of cap dependent proteins: synthesis, delivery and chaos
Project in Poland financed by DG Regio

    Statements

    0 references
    4,500,000.0 zloty
    0 references
    1,080,000.0 Euro
    13 January 2020
    0 references
    4,500,000.0 zloty
    0 references
    1,080,000.0 Euro
    13 January 2020
    0 references
    100.0 percent
    0 references
    1 June 2017
    0 references
    30 November 2021
    0 references
    UNIWERSYTET WARSZAWSKI
    0 references
    The project aims at the design, synthesis, and evaluation of novel mRNA 5’ cap analogs as selective inhibitors of three major cap-related proteins: the eukaryotic translation initiation factor 4E (eIF4E) and the two decapping enzymes (DcpS and Dcp2). The proteins were selected due to their key roles in mRNA function and an already-confirmed status as molecular targets for cancer and neuromuscular diseases. To achieve the goal, we propose a comprehensive approach encompassing 1) generation of novel cap derivatives, either by traditional chemical synthesis or by combinatorial approach based on in situ click chemistry, 2) ideas for novel molecular probes and screening approaches specifically tailored for each of the proteins, 3) in-depth evaluation of the found inhibitors using biophysical, biochemical, and structural methods to understand their mechanism of action at the molecular level, 4) application of several cell-delivery strategies to demonstrate the biological potential in vivo. (Polish)
    0 references
    The project approaches at the design, synthesis, and evaluation of novel mRNA 5’ caps as selective inhibitors of three major cage-related proteins:the eucartic translation ambiguity 4E (eIF4E) and the two decepping enzymes (DcpS and Dcp2).The proteins former due to their formal status in mRNA and neuromusculcular diseases.To achieve the good, in a comprehensive approach encompassing 1. (English)
    0 references

    Identifiers

    POIR.04.04.00-00-20A2/16
    0 references